Logo image of APR

APRIA INC (APR) Stock Fundamental Analysis

NASDAQ:APR - Nasdaq - Common Stock

37.5  +0.01 (+0.03%)

After market: 37.51 +0.01 (+0.03%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to APR. APR was compared to 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of APR have multiple concerns. While showing a medium growth rate, APR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year APR was profitable.
APR Yearly Net Income VS EBIT VS OCF VS FCFAPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 50M 100M 150M 200M

1.2 Ratios

Industry RankSector Rank
ROA 8.36%
ROE 163.17%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APR Yearly ROA, ROE, ROICAPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 100 -100

1.3 Margins

Industry RankSector Rank
OM 8.65%
PM (TTM) 5.66%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APR Yearly Profit, Operating, Gross MarginsAPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

APR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for APR has been reduced compared to a year ago.
APR Yearly Shares OutstandingAPR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 10M 20M 30M
APR Yearly Total Debt VS Total AssetsAPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

APR has an Altman-Z score of 1.39. This is a bad value and indicates that APR is not financially healthy and even has some risk of bankruptcy.
A Debt/Equity ratio of 8.58 is on the high side and indicates that APR has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 8.58
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACCN/A
WACCN/A
APR Yearly LT Debt VS Equity VS FCFAPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.09 indicates that APR should not have too much problems paying its short term obligations.
APR has a Quick Ratio of 1.06. This is a normal value and indicates that APR is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.06
APR Yearly Current Assets VS Current LiabilitesAPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

APR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.97%, which is quite impressive.
The earnings per share for APR have been decreasing by -11.35% on average. This is quite bad
The Revenue has been growing slightly by 3.30% in the past year.
APR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.62% yearly.
EPS 1Y (TTM)29.97%
EPS 3Y65.99%
EPS 5Y-11.35%
EPS Q2Q%-98.12%
Revenue 1Y (TTM)3.3%
Revenue growth 3Y1.02%
Revenue growth 5Y1.62%
Sales Q2Q%0.93%

3.2 Future

The Earnings Per Share is expected to grow by 7.08% on average over the next years.
The Revenue is expected to grow by 4.70% on average over the next years.
EPS Next Y5.86%
EPS Next 2Y6.66%
EPS Next 3Y6.76%
EPS Next 5Y7.08%
Revenue Next Year5.14%
Revenue Next 2Y4.96%
Revenue Next 3Y4.61%
Revenue Next 5Y4.7%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
APR Yearly Revenue VS EstimatesAPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
APR Yearly EPS VS EstimatesAPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

APR is valuated rather expensively with a Price/Earnings ratio of 21.43.
APR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.62.
The Price/Forward Earnings ratio is 20.24, which indicates a rather expensive current valuation of APR.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, APR is valued at the same level.
Industry RankSector Rank
PE 21.43
Fwd PE 20.24
APR Price Earnings VS Forward Price EarningsAPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.98
APR Per share dataAPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates APR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.66
PEG (5Y)N/A
EPS Next 2Y6.66%
EPS Next 3Y6.76%

More info and screens

0

5. Dividend

5.1 Amount

APR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APRIA INC

NASDAQ:APR (3/28/2022, 8:26:58 PM)

After market: 37.51 +0.01 (+0.03%)

37.5

+0.01 (+0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-28 2022-02-28/bmo
Earnings (Next)05-11 2022-05-11
Inst Owners0%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner Change0%
Market Cap1.34B
Analysts46.67
Price Target39.1 (4.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.43
Fwd PE 20.24
P/S 1.17
P/FCF N/A
P/OCF N/A
P/B 33.64
P/tB N/A
EV/EBITDA 6.98
EPS(TTM)1.75
EY4.67%
EPS(NY)1.85
Fwd EY4.94%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS32.14
BVpS1.11
TBVpSN/A
PEG (NY)3.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.36%
ROE 163.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.65%
PM (TTM) 5.66%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 8.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.06
Altman-Z 1.39
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.97%
EPS 3Y65.99%
EPS 5Y-11.35%
EPS Q2Q%-98.12%
EPS Next Y5.86%
EPS Next 2Y6.66%
EPS Next 3Y6.76%
EPS Next 5Y7.08%
Revenue 1Y (TTM)3.3%
Revenue growth 3Y1.02%
Revenue growth 5Y1.62%
Sales Q2Q%0.93%
Revenue Next Year5.14%
Revenue Next 2Y4.96%
Revenue Next 3Y4.61%
Revenue Next 5Y4.7%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A